Agitation & Alzheimer's Disease (AAD) Archives - Page 5 of 6

Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

Regional/Local April 3 12:00 pm to 1:00 pm PDT

Roshni Patel, PharmD, BCPS, and Elika Hefazi, PharmD, BCPP, are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) Read More

Agitation Associated With Alzheimer’s Dementia: Pathophysiology

Live Event May 17 6:30 pm to 8:30 pm EDT

Speakers Becky Wong, PharmD, MBA and Brijesh Patel, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical… Read More

Live Event – Agitation Associated With Alzheimer’s Dementia: Disease State

Live Event March 30 6:00 pm to 7:00 pm EDT

Speakers Sara A. Spencer, PharmD, MS, BCGP and Alyssa Weers, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by… Read More

Live Event – Current Guidelines & Unmet Needs In The Treatment Of Agitation Associated With Alzheimer’s Dementia

Live Event March 22 6:30 pm to 8:30 pm EDT

Speaker Mark Tacelosky, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read More

Unmet Needs In Agitation Associated With Alzheimer’s Dementia

Live Event July 18 6:00 pm to 8:30 pm CDT

In this discussion, current treatment guidelines, assess risk/benefit profile, and unmet needs of AAD treatment will be reviewed. Read More

Live Event – Current Guidelines & Unmet Needs In The Treatment Of Agitation Associated With Alzheimer’s Dementia

Live Event March 8 6:00 pm to 8:00 pm EST

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community;… Read More

Live Event – Current Guidelines & Unmet Needs In The Treatment Of Agitation Associated With Alzheimer’s Dementia

Live Event March 29 6:00 pm to 8:00 pm EDT

Speakers Anna Basoff, PharmD and Katie Sulkowski, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental… Read More

Live Event – Agitation Associated With Alzheimer’s Dementia Disease State Education: Disease State

Live Event February 15 6:00 pm to 8:30 pm CST

Speaker Heather Fields, PharmD, MPH, BCACP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental &… Read More

Live Event – Agitation Associated With Alzheimer’s Dementia Disease State Education: Disease State

Live Event February 22 6:00 pm to 8:30 pm CST

Live Event – Agitation Associated with Alzheimer’s Dementia: Pathophysiology

Live Event April 18 6:00 pm to 8:00 pm EDT

Speaker Alex Matushek PharmD., MBA is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: